CDH17 and colorectal carcinoma: Our results are in concordance with one of the few studies analyzing the CDH17 profile in CRC, which reports a link between high levels of CDH17 immunohistochemical expression and moderate and well-differentiated cases (low-grade), whereas diminished levels correlate with poorly differentiated cases (high-grade) [23].